Luye to provide investors with a dose of diversification

By Rev Hui
12 Jun 2014

Luye Pharma Group started premarketing a $800m Hong Kong IPO on June 11, with those on the deal confident that investor demand will be red hot.

Arranged by Citi, Citic Securities and UBS, the investor meetings will run for one and a half weeks, after which bookbuilding is scheduled to launch on June 23.

“We’re all predicting this one to go really well because it’s a sector everyone loves,” one banker close to the ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial